Insight Molecular Diagnostics (IMDX) Interest Coverage Ratio Growth (1y) (2016 - 2026)
Insight Molecular Diagnostics (IMDX) Interest Coverage Ratio Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.40 Bn | 209.33 Bn | 8.34 Bn | 14.65% |
| 2 | Danaher | 139.94 Bn | 135.59 Bn | 3.61 Bn | 3.80% |
| 3 | Idexx Laboratories | 46.03 Bn | 45.83 Bn | 779.09 Mn | -91.18% |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | 120.45% |
| 5 | Iqvia Holdings | 39.32 Bn | 37.24 Bn | 1.44 Bn | -7.61% |
| 6 | Natera | 38.47 Bn | 37.37 Bn | 696.04 Mn | 97.40% |
| 7 | Illumina | 29.98 Bn | 28.82 Bn | 770.00 Mn | -28.45% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.52 Bn | 650.22 Mn | -11.26% |
| 9 | Quest Diagnostics | 26.21 Bn | 25.58 Bn | 1.03 Bn | 10.67% |
| 10 | Insight Molecular Diagnostics | 172.60 Mn | 143.67 Mn | 15,000.00 | 36.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.63% |
| Dec 31, 2025 | 40.90% |
| Sep 30, 2025 | -256.20% |
| Jun 30, 2025 | 70.42% |
| Mar 31, 2025 | 8.09% |
| Dec 31, 2024 | -224.24% |
| Sep 30, 2024 | 99.19% |
| Jun 30, 2024 | 93.85% |
| Mar 31, 2024 | -135.35% |
| Dec 31, 2023 | 7.77% |
| Sep 30, 2023 | -46,894.68% |
| Jun 30, 2023 | -31,294.98% |
| Mar 31, 2023 | 2,687.16% |
| Dec 31, 2022 | 68.71% |
| Sep 30, 2022 | 87.25% |
| Jun 30, 2022 | 98.96% |
| Mar 31, 2022 | 56.44% |
| Dec 31, 2021 | -765.30% |
| Sep 30, 2021 | 38.46% |
| Jun 30, 2021 | -412.39% |